EuroIntervention PCRonline - Connecting with the community

Just accepted article

Non-invasive Heart Team Assessment of Multivessel Coronary Disease with Coronary Computed Tomography Angiography Based on SYNTAX Score II Treatment Recommendations: Design and Rationale of the Randomized SYNTAX III Revolution trial

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Erasmus MC, NETHERLANDS; 2. Erasmus MC, Rotterdam, The Netherlands; 3. Academic Medical Center, Amsterdam, The Netherlands; 4. Academic Medical Center, Amsterdam, The Netherlands; 5. GE Healthcare, Waukesha, WI, USA; 6. Heartflow Inc., Redwood City, CA, USA; 7. Erasmus MC, Rotterdam, The Netherlands; 8. Erasmus MC, Rotterdam, The Netherlands; 9. Academic Medical Center, Amsterdam, The Netherlands; 10. Erasmus MC, Rotterdam, The Netherlands; 11. Academic Medical Center, Amsterdam, The Netherlands; 12. Cardialysis BV, Rotterdam, The Netherlands; 13. Imperial College London, London, UK

Abstract

Aims:To investigate whether a heart-team decision-making process regarding the choice of revascularization strategy based on non-invasive coronary multislice computed tomography angiography (MSCT) assessment of coronary artery disease (CAD) is equivalent to the standard-of-care invasive angiography based assessment in patients with multivessel CAD.

Methods and results:The SYNTAX III Revol…

– OR –